CRLBF
Price
$0.94
Change
+$0.06 (+6.82%)
Updated
Jan 30 closing price
Capitalization
501.04M
41 days until earnings call
JUSHF
Price
$0.32
Change
+$0.02 (+6.67%)
Updated
Jan 30 closing price
Capitalization
94.38M
97 days until earnings call
Ad is loading...

CRLBF vs JUSHF

Header iconCRLBF vs JUSHF Comparison
Open Charts CRLBF vs JUSHFBanner chart's image
Cresco Labs
Price$0.94
Change+$0.06 (+6.82%)
Volume$274.67K
Capitalization501.04M
Jushi Holdings
Price$0.32
Change+$0.02 (+6.67%)
Volume$45.19K
Capitalization94.38M
CRLBF vs JUSHF Comparison Chart
Loading...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JUSHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRLBF vs. JUSHF commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRLBF is a Hold and JUSHF is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 31, 2025
Stock price -- (CRLBF: $0.94 vs. JUSHF: $0.32)
Brand notoriety: CRLBF and JUSHF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRLBF: 35% vs. JUSHF: 21%
Market capitalization -- CRLBF: $501.04M vs. JUSHF: $94.38M
CRLBF [@Pharmaceuticals: Other] is valued at $501.04M. JUSHF’s [@Pharmaceuticals: Other] market capitalization is $94.38M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRLBF’s FA Score shows that 0 FA rating(s) are green whileJUSHF’s FA Score has 0 green FA rating(s).

  • CRLBF’s FA Score: 0 green, 5 red.
  • JUSHF’s FA Score: 0 green, 5 red.
According to our system of comparison, JUSHF is a better buy in the long-term than CRLBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRLBF’s TA Score shows that 2 TA indicator(s) are bullish while JUSHF’s TA Score has 2 bullish TA indicator(s).

  • CRLBF’s TA Score: 2 bullish, 2 bearish.
  • JUSHF’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, CRLBF is a better buy in the short-term than JUSHF.

Price Growth

CRLBF (@Pharmaceuticals: Other) experienced а +10.72% price change this week, while JUSHF (@Pharmaceuticals: Other) price change was +10.28% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.18%. For the same industry, the average monthly price growth was +2.96%, and the average quarterly price growth was -7.06%.

Reported Earning Dates

CRLBF is expected to report earnings on May 14, 2025.

JUSHF is expected to report earnings on May 22, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.18% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRLBF($501M) has a higher market cap than JUSHF($94.4M). JUSHF YTD gains are higher at: 2.830 vs. CRLBF (2.388). CRLBF has higher annual earnings (EBITDA): -16.73M vs. JUSHF (-106.76M). CRLBF has more cash in the bank: 88.8M vs. JUSHF (18.5M). JUSHF has less debt than CRLBF: JUSHF (309M) vs CRLBF (678M). CRLBF has higher revenues than JUSHF: CRLBF (822M) vs JUSHF (292M).
CRLBFJUSHFCRLBF / JUSHF
Capitalization501M94.4M531%
EBITDA-16.73M-106.76M16%
Gain YTD2.3882.83084%
P/E RatioN/AN/A-
Revenue822M292M282%
Total Cash88.8M18.5M480%
Total Debt678M309M219%
FUNDAMENTALS RATINGS
CRLBF vs JUSHF: Fundamental Ratings
CRLBF
JUSHF
OUTLOOK RATING
1..100
1432
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JUSHF's Valuation (50) in the null industry is in the same range as CRLBF (56). This means that JUSHF’s stock grew similarly to CRLBF’s over the last 12 months.

JUSHF's Profit vs Risk Rating (100) in the null industry is in the same range as CRLBF (100). This means that JUSHF’s stock grew similarly to CRLBF’s over the last 12 months.

CRLBF's SMR Rating (94) in the null industry is in the same range as JUSHF (100). This means that CRLBF’s stock grew similarly to JUSHF’s over the last 12 months.

CRLBF's Price Growth Rating (65) in the null industry is in the same range as JUSHF (65). This means that CRLBF’s stock grew similarly to JUSHF’s over the last 12 months.

CRLBF's P/E Growth Rating (100) in the null industry is in the same range as JUSHF (100). This means that CRLBF’s stock grew similarly to JUSHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLBFJUSHF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
89%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 25 days ago
83%
Bullish Trend 30 days ago
89%
Declines
ODDS (%)
N/A
Bearish Trend 24 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JUSHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMSC27.311.21
+4.64%
American Superconductor Corp
SCL64.350.63
+0.99%
Stepan Co
NVDA124.650.95
+0.77%
NVIDIA Corp
ALLT8.37-0.12
-1.47%
Allot Ltd
QRVO83.72-2.31
-2.69%
Qorvo

CRLBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRLBF has been closely correlated with TSNDF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRLBF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
+5.83%
TSNDF - CRLBF
76%
Closely correlated
+2.75%
CURLF - CRLBF
76%
Closely correlated
+12.25%
TCNNF - CRLBF
75%
Closely correlated
+0.72%
JUSHF - CRLBF
74%
Closely correlated
+5.75%
VRNOF - CRLBF
73%
Closely correlated
+4.02%
More